Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course covered outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and focused around two practical scenarios in which participants could gain experience in managing an acute epidemic.
Communicable disease threats report, 12-18 November 2017, Week 46
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 12-18 November 2017 and includes updates on Legionnaires' disease, influenza, West Nile fever, chikungunya, yellow fever, plague, monkeypox, marburg virus disease, malaria and cholera.
WHO Guidance for Surveillance during an Influenza Pandemic
This guidance is an update to an earlier document “Global surveillance during an influenza pandemic”, published in April 2009. It takes the lesions learned from the 2009 influenza pandemic into consideration and focuses on the key surveillance components needed during an influenza pandemic. The purpose of the updated guidance is to outline the surveillance strategies and essential data requirements that Member States can use throughout the course of an influenza pandemic to ensure informed risk management decisions in pandemic response and fulfilment of IHR (2005) core capacity requirements.
European Commission: Influenza
Vaccination policy is a competence of national authorities however, the European Commission supports EU countries to coordinate their policies and programmes. To support EU countries in maintaining or increasing rates of vaccination, the EU Commission promotes seasonal flu vaccination to at risk groups.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
Influenza vaccination coverage among high-risk groups has dropped in the European Region over the last seven years, and half the countries report a decrease in the number of vaccine doses available.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
Weekly influenza surveillance overview, Nov 15, 2013 - week 45
During week 45/2013: All 27 reporting countries experienced low intensity influenza activity.
Weekly influenza surveillance overview, Nov 22, 2013 - week 46
During week 46/2013: All 28 reporting countries experienced low intensity influenza activity